Clinical trial

Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

NCT03267329

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Duowell® Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Telmisartan Normalized identity: telmisartanView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-09-11

PhasePHASE4

Conditions

Hypertensionunresolved

Dyslipidemiaunresolved

Interventions

Duowell®DRUG

TelmisartanDRUG · verified · RxNorm: telmisartan

Sponsors & collaborators

Yuhan Corporationlead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03267329 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.